Literature DB >> 10329425

EGF-induced activation of Stat1, Stat3, and Stat5b is unrelated to the stimulation of DNA synthesis in cultured hepatocytes.

T K Guren1, H Abrahamsen, G H Thoresen, E Babaie, T Berg, T Christoffersen.   

Abstract

Transcription factors of the STAT family have been implicated in regulation of cell proliferation. EGF activates several STAT proteins in liver. We have studied the relationship between STAT activation and the growth-stimulatory effect of EGF in rat hepatocytes, assessing specific DNA-binding activity of STAT proteins in electrophoretic mobility-shift and supershift assays. In freshly isolated hepatocytes, EGF activated Stat1, Stat3, and, particularly, Stat5b. However, the ability of EGF to produce this activation was rapidly attenuated when the cells were cultured, while the activation by IFN-gamma (Stat1) and IL-6 (Stat3) was sustained. Hepatocytes cultured for 24-48 h are highly sensitive to the stimulatory effect of EGF on S phase entry. In these cells EGF did not detectably activate Stat1, Stat3, or Stat5b but markedly stimulated MAP kinase (Erk1/2). Thus, although EGF has the ability to activate several STAT proteins, this did not seem to be part of the mitogenic mechanisms used by the EGF receptor in hepatocytes. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329425     DOI: 10.1006/bbrc.1999.0684

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway.

Authors:  Nikolas Balanis; Michael K Wendt; Barbara J Schiemann; Zhenghe Wang; William P Schiemann; Cathleen R Carlin
Journal:  J Biol Chem       Date:  2013-05-07       Impact factor: 5.157

2.  Cross talk between the TM4SF5/focal adhesion kinase and the interleukin-6/STAT3 pathways promotes immune escape of human liver cancer cells.

Authors:  Jihye Ryu; Minkyung Kang; Mi-Sook Lee; Hye-Jin Kim; Seo Hee Nam; Haeng Eun Song; Doohyung Lee; Jung Weon Lee
Journal:  Mol Cell Biol       Date:  2014-06-09       Impact factor: 4.272

3.  EGFR: A Master Piece in G1/S Phase Transition of Liver Regeneration.

Authors:  Alexandra Collin de L'hortet; Hélène Gilgenkrantz; Jacques-Emmanuel Guidotti
Journal:  Int J Hepatol       Date:  2012-09-23

4.  Voting-based cancer module identification by combining topological and data-driven properties.

Authors:  A K M Azad; Hyunju Lee
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

5.  Sorafenib and CuB exert synergistic antitumor effects against hepatocellular carcinoma cells via inhibition of STAT3 phosphorylation.

Authors:  Xiaoli Wang; Hua Li; Dong Li; Yudi Bai; Yao Zhang; Xue Yan; Jin Li; Ri Zhao; Jiahui Liu; Wei Liu; Maolin Shi; Cheng Xu; Tai Yang; Tao Zhang
Journal:  FEBS Open Bio       Date:  2020-11-27       Impact factor: 2.792

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.